Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€2.36

€2.36

13.460%
0.28
13.460%
-
 
28.03.24 / Stuttgart Stock Exchange WKN: A14QUF / Name: Check Cap / Stock / Pharmaceuticals / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Check Cap Ltd Stock

A very strong showing by Check Cap Ltd today, with an increase of €0.28 (13.460%) compared to yesterday's price.
Our community identified positive and negative aspects for Check Cap Ltd stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Check Cap Ltd stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.

Pros and Cons of Check Cap Ltd in the next few years

Pros
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Check Cap Ltd vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Check Cap Ltd 13.460% 24.551% 1.961% 62.703% 6.667% 33.333% -
Beximco Pharmaceuticals Ltd. GDR - -7.234% 0.000% 4.808% -0.909% -57.255% -14.510%
Cellectar BioSciences Inc. 10.780% 4.494% 2.198% 181.818% 63.158% -73.803% -
SELLAS Life Sciences Group Inc -1.570% -1.271% -1.062% -15.847% -4.410% -86.936% -99.746%

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-05-13

From an initial glance at the financial statements of Check Cap, a pharmaceutical company with the US symbol, it appears that the company has been experiencing some financial challenges. Over the years, the company's balance sheets and income statements reveal issues that may be concerning for investors. In order to provide a better understanding of Check Cap's financial performance, let us dive into a detailed analysis.

Pros

Decreasing Total Liabilities: Over the years, it is evident that Check Cap has successfully reduced its total liabilities. The total liabilities decreased from $4,968,000 in 2021 to $4,129,000 in 2022, potentially showing the company's ability to effectively manage its debt obligations.

Comments

Prediction Sell
Perf. (%) -4.64%
Target price
Change
Ends at 29.03.22

Sell Check Cap Ltd
Show more

Buy Check Cap Ltd
Show more

Sell Check Cap Ltd
Show more